- Home
- ONTO vs NBY Comparison
ONTO vs NBY Comparison
Compare ONTO & NBY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONTO
- NBY
- Stock Information
- Founded
- ONTO 1940
- NBY 2000
- Country
- ONTO United States
- NBY United States
- Employees
- ONTO N/A
- NBY N/A
- Industry
- ONTO Industrial Machinery/Components
- NBY
- Sector
- ONTO Industrials
- NBY
- Exchange
- ONTO Nasdaq
- NBY Nasdaq
- Market Cap
- ONTO 8.0B
- NBY 3.3M
- IPO Year
- ONTO N/A
- NBY 2007
- Fundamental
- Price
- ONTO $167.30
- NBY $0.53
- Analyst Decision
- ONTO Strong Buy
- NBY Strong Buy
- Analyst Count
- ONTO 8
- NBY 1
- Target Price
- ONTO $254.29
- NBY $0.85
- AVG Volume (30 Days)
- ONTO 694.2K
- NBY 82.3K
- Earning Date
- ONTO 02-06-2025
- NBY 11-07-2024
- Dividend Yield
- ONTO N/A
- NBY N/A
- EPS Growth
- ONTO 16.27
- NBY N/A
- EPS
- ONTO 3.70
- NBY N/A
- Revenue
- ONTO $942,238,000.00
- NBY $13,844,000.00
- Revenue This Year
- ONTO $23.06
- NBY N/A
- Revenue Next Year
- ONTO $16.73
- NBY $26.04
- P/E Ratio
- ONTO $45.19
- NBY N/A
- Revenue Growth
- ONTO 10.81
- NBY 15.40
- 52 Week Low
- ONTO $134.11
- NBY $0.36
- 52 Week High
- ONTO $238.93
- NBY $9.10
- Technical
- Relative Strength Index (RSI)
- ONTO 45.31
- NBY 39.55
- Support Level
- ONTO $163.45
- NBY $0.49
- Resistance Level
- ONTO $182.34
- NBY $0.58
- Average True Range (ATR)
- ONTO 6.04
- NBY 0.03
- MACD
- ONTO 1.14
- NBY -0.01
- Stochastic Oscillator
- ONTO 26.71
- NBY 36.27
About ONTO Onto Innovation Inc.
Onto Innovation Inc is engaged in the design, development, manufacture, and support of high-performance control metrology, defect inspection, lithography, and data analysis systems used by microelectronics device manufacturers. The Company and its subsidiaries currently operate in a single operating segment. The company mainly operates in the United States, Southeast Asia, China, Japan, and Europe, with Taiwan and South Korea the largest sources of total revenue.
About NBY NovaBay Pharmaceuticals Inc.
NovaBay Pharmaceuticals Inc is a biopharmaceutical company that develops and sells scientifically-created and clinically eyecare and skincare products. Its product, Avenova Antimicrobial Lid and Lash Solution (Avenova Spray), is laboratory tested to have broad antimicrobial properties as it removes foreign material including microorganisms and debris from the skin around the eye, including the eyelid. Avenova Spray is available directly to consumers through online distribution channels and is also often prescribed and dispensed by eyecare professionals for blepharitis and dry-eye disease. It has two reportable segments: Eyecare and Wound Care and Skincare.